Prognosis
Deceased AstraZeneca Trial Volunteer Didn’t Receive Vaccine
- Drugmaker’s shares retrace earlier losses after news of death
- U.S. clinical trial of the drugmaker’s vaccine remains on hold
This article is for subscribers only.
A participant who died during a trial of AstraZeneca Plc’s Covid-19 vaccine in Brazil hadn’t received the company’s shot, according to a person familiar with the matter.
The person asked not to be identified because the information isn’t public.